 "Covid-19 pandemic: Bharat Biotech's Covaxin ready for dispatch at new plant")
Covaxin batches at Bharat Biotech’s Ankleshwar facility are expected to be available for the national pool from next month onwards for both public and private sector consumption, Suchitra Ella, joint MD of Bharat Biotech said at CII.
The doses are ready to be dispatched to the Central Drugs Laboratory in Kasauli for quality and sterility inspection this month.
Health minister Mansukh Mandaviya said that the government wants to increase the share of generic medicine in the health sector which has gone up to 8 per cent. “India’s pharma sector has to become self-reliant and it should become a global leader,” Mandaviya said.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%